Quantitation of telomerase activity in hepatocellular carcinoma: A possible aid for a prediction of recurrent diseases in the remnant liver

被引:46
作者
Suda, T
Isokawa, O
Aoyagi, Y
Nomoto, M
Tsukada, K
Shimizu, T
Suzuki, Y
Naito, A
Igarashi, H
Yanagi, M
Takahashi, T
Asakura, H
机构
[1] Niigata Univ, Sch Med, Dept Internal Med 3, Niigata 951, Japan
[2] Niigata Univ, Sch Med, Dept Surg 1, Niigata 951, Japan
[3] Shinrakuen Hosp, Div Surg, Niigata, Japan
关键词
D O I
10.1002/hep.510270213
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Because telomerase activity is necessary for cell immortality and probably associated with tumor progression, we have evaluated a possible aid for quantitation of the activity to predict intrahepatic recurrences after surgery in patients with hepatocellular carcinoma (HCC). HCC tissues obtained by surgical resection from 20 patients were studied. Telomerase activity was expressed as peaks with a periodicity through a fluorescence-based telomeric repeat amplification protocol using an autosequencer, and the quantity of activity was calculated from peak areas. A ratio of fluorescence intensity depending on telomerase to that of an internal standard was used as a value of relative telomerase activity (RTA). RTA ia serially diluted S100 extracts from HepG2 cells was well correlated with the amount of the extracts. The mean RTA value of 36.4 +/- 27.8 (mean +/- SD, 3.21 to 105) in 9 patients suffering from early recurrences after surgery was significantly higher than that (9.84 +/- 7.65; mean +/- SD, 3.00 to 29.0) in 11 patients without intrahepatic recurrences during the early period (P = .004). These results indicate that RTA value can be a useful predictor for intrahepatic recurrences during the early period after surgical resection of HCC.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 28 条
[1]   TELOMERE LENGTH PREDICTS REPLICATIVE CAPACITY OF HUMAN FIBROBLASTS [J].
ALLSOPP, RC ;
VAZIRI, H ;
PATTERSON, C ;
GOLDSTEIN, S ;
YOUNGLAI, EV ;
FUTCHER, AB ;
GREIDER, CW ;
HARLEY, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10114-10118
[2]  
CHADENEAU C, 1995, CANCER RES, V55, P2533
[3]   TELOMERASE ACTIVITY IN NORMAL LEUKOCYTES AND IN HEMATOLOGIC MALIGNANCIES [J].
COUNTER, CM ;
GUPTA, J ;
HARLEY, CB ;
LEBER, B ;
BACCHETTI, S .
BLOOD, 1995, 85 (09) :2315-2320
[4]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[5]  
2-E
[6]   ADENOMATOUS HYPERPLASIA IN THE VICINITY OF SMALL HEPATOCELLULAR-CARCINOMA [J].
EGUCHI, A ;
NAKASHIMA, O ;
OKUDAIRA, S ;
SUGIHARA, S ;
KOJIRO, M .
HEPATOLOGY, 1992, 15 (05) :843-848
[7]   THE RNA COMPONENT OF HUMAN TELOMERASE [J].
FENG, JL ;
FUNK, WD ;
WANG, SS ;
WEINRICH, SL ;
AVILION, AA ;
CHIU, CP ;
ADAMS, RR ;
CHANG, E ;
ALLSOPP, RC ;
YU, JH ;
LE, SY ;
WEST, MD ;
HARLEY, CB ;
ANDREWS, WH ;
GREIDER, CW ;
VILLEPONTEAU, B .
SCIENCE, 1995, 269 (5228) :1236-1241
[8]   A TELOMERIC SEQUENCE IN THE RNA OF TETRAHYMENA TELOMERASE REQUIRED FOR TELOMERE REPEAT SYNTHESIS [J].
GREIDER, CW ;
BLACKBURN, EH .
NATURE, 1989, 337 (6205) :331-337
[9]   IDENTIFICATION OF A SPECIFIC TELOMERE TERMINAL TRANSFERASE-ACTIVITY IN TETRAHYMENA EXTRACTS [J].
GREIDER, CW ;
BLACKBURN, EH .
CELL, 1985, 43 (02) :405-413
[10]  
Hermanek P., 1987, TNM Classification of Malignant Tumors, V4th edn